In the present study, the frequency of two populations of circulating T cells, activated TPH and activated CD8 T cells are significantly higher in the blood of patients with an active AIH compared to AIH patients in remission, and to patients with NASH, taken as a control group presenting liver inflammation, without autoimmunity. Here, TPH1 is linked to metabolic dysfunction-associated steatohepatitis.